American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 single dose escalation study of palifermin administered pre-transplant conditioning in subjects undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Ostojic, A.; Holtzman, N. G.; Curtis, L. M.; Shaffer, B. C.; Rubin, J. S.; Hakim, F. T.; Mays, J. W.; Heller, T.; Cowen, E. W.; Werner, S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Infusion-related reactions (IRRs) in the DREAMM-2 Study of single-agent belantamab mafodotin (belamaf) in patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nooka, A.; Lee, H. C.; Badros, A. Z.; Voorhees, P.; Hultcrantz, M.; Karlin, L.; Arnulf, B.; Richardson, P. G.; Zhi, E.; Baron, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A multi-center, dose-finding study to assess safety, tolerability, pharmacokinetics and preliminary efficacy of a novel IRAK4 inhibitor CA-4948 in combination with ibrutinib, in patients with relapsed or refractory hematologic malignancies
    Meeting Abstract

    Nowakowski, G. S.; Leslie, L. A.; Joffe, E.; Rosenthal, A. C.; Lunning, M. A.; Patel, K.; Mead, M.; Landsburg, D. J.; Fenske, T. S.; Ramchandren, R.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Safety, pharmacokinetics and activity of CA-4948, an IRAK4 inhibitor, for treatment of patients with relapsed or refractory hematologic malignancies: Results from the phase 1 study
    Meeting Abstract

    Nowakowski, G. S.; Leslie, L. A.; Younes, A.; Rosenthal, A. C.; Lunning, M. A.; Patel, K.; Landsburg, D. J.; Martinez, E.; von Roemeling, R.; Lieberman, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals evidence of two biologically and clinically distinct entities: Progressive versus stable myeloma precursor disease
    Meeting Abstract

    Oben, B.; Froyen, G.; Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Abascal, F.; Leongamornlert, D. A.; Derkach, A.; Geerdens, E.; Diamond, B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A multi-center biologic assignment trial comparing reduced intensity allogeneic hematopoietic cell transplantation to hypomethylating therapy or best supportive care in patients aged 50-75 with advanced myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network Study 1102
    Meeting Abstract

    Nakamura, R.; Saber, W.; Martens, M. J.; Ramirez, A.; Scott, B. L.; Oran, B.; Leifer, E.; Tamari, R.; Mishra, A.; Maziarz, R. T.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Single-cell multi-omics in human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation
    Meeting Abstract

    Nam, A. S.; Dusaj, N.; Izzo, F.; Murali, R.; Mouhieddine, T. H.; Myers, R. M.; Sotelo, J.; Benbarche, S.; Gaiti, F.; Tahri, S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Post-treatment clone size predicts survival independently of IPSS-R and response after azacitidine therapy for MDS
    Meeting Abstract

    Nannya, Y.; Tobiasson, M.; Sato, S.; Bernard, E.; Creignou, M.; Zhao, L.; Takeda, J.; Shiraishi, Y.; Chiba, K.; Tanaka, H.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Transcriptional control of HP1a by the RNA binding proteins RBMX/L1 maintain chromatin state in myeloid leukemia
    Meeting Abstract

    Nguyen, D. T. T.; Prieto, C.; Liu, Z.; Wheat, J.; Perez, A.; Gourkanti, S.; Chou, T.; Barin, E.; Chow, A.; Taggart, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation (allo-HCT) in T-cell prolymphocytic leukemia (T-PLL): An analysis from the CIBMTR
    Meeting Abstract

    Murthy, H. S.; Ahn, K. W.; Estrada-Merly, N.; Gowda, L.; Dholaria, B.; Bal, S.; Alkhateeb, H. B.; Jagadeesh, D.; Oran, B.; Nakamura, R.; more...
    Blood (2020)

    Fulltext@MSK | Save